Cat.#: ACPP-1502
Despition | DAG1 Human Recombinant |
SIZE | 2 µg |
Purity | Purity as determined by densitometric image analysis is > 90%. |
Form | Filtered White lyophilized (freeze-dried) powder. |
Storage | Lyophilized was stored at -20°C to -80°C, while reconstituted was aliquot and stored at -80°C. Avoid freeze/thaw cycles. |
Shipping | Shipped at 4°C |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Size | Price |
---|---|---|---|
ACPP-1186 | Olig2 Blocking Peptide (AC1186) | 250 µg | inquiry |
ACPP-1019 | Recombinant Human GPRC5A Protein (Fc Tag) (AC1019) | 50 µg | inquiry |
ACPP-1623 | Human USH1C Protein (AC1623) | 5 µg | inquiry |
ACPP-1846 | Human FGF 9 Protein (AC1846) | 5 µg | inquiry |
ACPP-1774 | Human CRKL Protein (AC1774) | 5 µg | inquiry |
ACPP-1299 | Calretinin Blocking Peptide (AC1299) | 250 µg | inquiry |
ACPP-1393 | Human ALDH3A1 Protein (AC1393) | 2 µg | inquiry |
ACPP-1239 | PDE7B Blocking Peptide (AC1239) | 250 µg | inquiry |
ACPP-1194 | Calcium Sensing Receptor Blocking Peptide (AC1194) | 250 µg | inquiry |
ACPP-1228 | Mouse IL 6 Protein (AC1228) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.